Novo Nordisk | Ativos

Assets Alterar Data
ANI Pharmaceuticals USD 914.52M 10.1M 2024-03
Aurora Cannabis CAD 817.17M 1.2M 2023-12
Bausch Health Companies USD 26.91B 437M 2024-03
Bristol-Myers Squibb USD 99.03B 7.77B 2024-03
Canopy Growth CAD 1.3B 59.42M 2024-03
Catalent USD 9.88B 109M 2024-03
Corcept Therapeutics USD 655.94M 34.42M 2024-03
Drreddys Laboratories INR 372.84B 25.82B 2023-12
Eli Lilly USD 63.94B 6.03B 2024-03
GlaxoSmithKline GBP 58.51B 494M 2024-03
Merck USD 105.85B 878M 2024-03
Novartis USD 94.33B 5.61B 2024-03
Novo Nordisk DKK 298.92B 15.57B 2024-03
Pacira USD 1.58B 8.93M 2024-03
Perrigo USD 10.64B 168.8M 2024-03
Prestige Brands USD 3.32B 21.34M 2024-03
Supernus Pharmaceuticals USD 1.3B 26.42M 2024-03
Zoetis USD 14.35B 62M 2024-03



Novo Nordisk Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.